New Risk Calculator May Help Men With High PSA Decide on Having Prostate Biopsy

New Risk Calculator May Help Men With High PSA Decide on Having Prostate Biopsy
A new risk calculator may help men with high levels of prostate-specific antigen (PSA) — a marker of prostate cancer — to decide if they should undergo a prostate biopsy to determine if they have cancer. The cancer risk calculator, developed by researchers at Kaiser Permanente Northern California, is specifically designed to calculate the risk each patient has of having either low- or high-grade cancer, or no cancer at all. It is designed for men with high PSA levels or who have had abnormal findings in a digital rectal exam. The development and validation of the risk calculator was reported in “Prospective development of a prostate cancer risk calculator in a racially diverse population: The Kaiser Permanente Prostate Cancer Risk Calculator,” a study published in the journal Urologic Oncology. For many years, physicians have debated whether men should have their PSA levels checked annually as part of a routine screening for prostate cancer. The issue with PSA is that the test h
Subscribe or to access all post and page content.